CLEVELAND, OH – June 13, 2016
Arix Bioscience, a global healthcare and life science company supporting medical innovation, announced that it will provide development capital to OptiKira, a BioMotiv portfolio company focused on fighting blindness. Arix Bioscience and BioMotiv have a strategic partnership committed to accelerating breakthrough discoveries.

Click here to read more